Corrigendum to “Cholesterol-Lowering Probiotics as Potential Biotherapeutics for Metabolic Diseases”
Saved in:
| Main Authors: | Manoj Kumar, Ravinder Nagpal, Rajesh Kumar, R. Hemalatha, Vinod Verma, Ashok Kumar, Chaitali Chakraborty, Birbal Singh, Francesco Marotta, Shalini Jain, Hariom Yadav |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-01-01
|
| Series: | Journal of Diabetes Research |
| Online Access: | http://dx.doi.org/10.1155/2022/3952529 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Trends in industrialization of biotherapeutics: a survey of product characteristics of 89 antibody-based biotherapeutics
by: Kyle P. Martin, et al.
Published: (2023-12-01) -
Probiotic Microorganisms in Inflammatory Bowel Diseases: Live Biotherapeutics as Food
by: Emanuelle Natalee Santos, et al.
Published: (2024-12-01) -
Biotherapeutic potentials of diverse probiotics of the Himalayan region: A Review
by: Nikita Bahuguna, et al.
Published: (2025-01-01) -
Deciphering the Gut–Liver Axis: A Comprehensive Scientific Review of Non-Alcoholic Fatty Liver Disease
by: Samradhi Singh, et al.
Published: (2024-09-01) -
Probiotic and Biotherapeutic Properties of Tannase Positive Lactobacillus plantarum ÌÒÑÑ 6 Strain
by: I. B. Oriabinska, et al.
Published: (2020-05-01)